Furosemide Tablets Solicitation
Closed Pre-Solicitation Posted
- Solicitation number
- SPE2D2-26-R-0005
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
Defense Logistics Agency Troop Support Medical Supply Chain is procuring a national requirements contract for Furosemide Tablets with a response deadline of July 2, 2026. This is an unrestricted, fully competitive commercial acquisition with no set-aside.
The contract covers furosemide tablets in three strengths and multiple package configurations: 20 mg and 40 mg in 90-count and 1,000-count bottles, and 80 mg in 500-count bottles. DLA is procuring on behalf of Department of Defense, Department of Veterans Affairs, Bureau of Prisons, and Indian Health Service customers. Contract structure is firm-fixed-price, requirements type with a one-year base period and four one-year options. Estimated annual quantity across all line items totals approximately 291,211 units, with specific demand projections provided in the solicitation appendix.
As a commercial item solicitation under FAR Part 12, all sources may submit proposals and will be evaluated on lowest-price technically acceptable (LPTA) basis. Proposals must address FDA cGMP manufacturing compliance, product registration with RXNorm, First Data Bank, and Medi-Span within five days of award, and GS1-128 bar code labeling standards. The contractor must establish distribution agreements with designated pharmaceutical prime vendors (AmerisourceBergen, Cardinal Health, DMS Pharmaceutical Group, and McKesson) and remit quarterly cost recovery fees of 0.5 percent of contract sales to the U.S. Treasury. Contract performance commences 45 calendar days after award, with prices effective 15 days thereafter.
Solicitation SPE2D226R0005 posts to DIBBS and SAM.gov. Contact Nancy Fernandez at (445) 737-0713 or Nancy.Fernandez@dla.mil. The closing date has been extended three times; current deadline is July 2, 2026, 3:00 PM EDT.
Notice text
5 versions
Update #5 · Latest ·
Amendment 3 issued to extend closing to July 2nd, 2026, 3:00 PM EDT.
Update #4 ·
Amendment 2 issued to extend closing to June 18th, 2026, 3:00 PM EST.
Update #3 ·
Amendment to extend closing to June 4th, 2026, 3:00 PM EST.
Update #2 ·
Furosemide Solicitation attached.
Update #1 ·
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Furosemide Tablets. Procurement details follow.
Furosemide Tablets: 20 MG and 40 MG in 90 and 1,000 count bottles and 80 MG in 500 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Bureau of Prisons, and Indian Health Service customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://sam.gov. Interested parties should contact Nancy Fernandez at (445) 737-0713 or Nancy.Fernandez@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is April of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Files
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity